1. bookVolume 26 (2020): Issue 2 (May 2020)
Journal Details
License
Format
Journal
First Published
16 Feb 2013
Publication timeframe
4 times per year
Languages
English
access type Open Access

Diagnostic and Therapeutic Challenges in Hepatocellular Carcinoma

Published Online: 01 Jul 2021
Page range: 76 - 79
Journal Details
License
Format
Journal
First Published
16 Feb 2013
Publication timeframe
4 times per year
Languages
English
Abstract

Introduction: Early detection of hepatocellular carcinoma is essential to provide effective therapy to high-risk patients, including patients with viral cirrhosis (eg HBV, HCV), haemochromatosis, alpha 1 antitrypsin deficiency or alcohol users.

Material and method: The group of patients studied was represented by patients from the records of the Medical Clinic I of the Clinical Hospital “Saint Andrew the Apostle” Constanța for a period of 3 years (2017-2019). We included 82 patients aged between 32 and 82 years (60.22 ± 10.66 years) of which 55 were male and 27 were female.

Results: Out of a total of 82 patients, 74 (90.25%) had cirrhosis (CH) and a number of 8 patients (9.75%) had chronic hepatitis without cirrhosis. Child-Pugh stage B had the highest prevalence among patients with hepatic cirrhosis. The etiological factor was hepatitis C virus infection 46 patients (56.1%), followed by hepatitis B virus infection 23 patients (28.05%), 4 patients (4.87%) had double hepatitis virus infection ( HBV + HCV), and 9 patients (10.98%) had a mixed viral and ethanolic etiology. Most of the lesions were located in the right hepatic lobe 58 patients (70.74%), respectively right + left hepatic lobe 22 patients (26.83%) and in 2 patients (2.44%) there were no visualized liver nodules. All patients had parenchymal fibrosis.

Conclusions: It is recommended to screen patients with chronic liver disease to assess the risk of developing hepatocellular carcinoma, initially by liver ultrasound that can accurately detect and locate suspected nodules later the definite diagnosis of hepatocellular carcinoma is confirmed by magnetic resonance imaging (MRI).

Keywords

1. Hepatocellular carcinoma - United States, 2001-2006 - PubMed [Internet]. [cited 2021 Feb 4]. Available from: https://pubmed.ncbi.nlm.nih.gov/20448528/ Search in Google Scholar

2. Balogh J, Victor D 3rd, Asham EH, Burroughs SG, Boktour M, Saharia A, et al. Hepatocellular carcinoma: a review. J Hepatocell carcinoma. 2016;3:41–53. Search in Google Scholar

3. Taran N, Dumbrava V-T, Tofan-Scutaru L. Hepatocarcinomul celular: raspandire, factori de risc si optiuni de tratament. Sanat publica,Economie si Manag Med. 2014;5(56):138–42. Search in Google Scholar

4. Bosetti C, Levi F, Boffetta P, Lucchini F, Negri E, La Vecchia C. Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004. Hepatology. 2008 Jul;48(1):137–45. Search in Google Scholar

5. European Association for the Study of the liver. EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 2012;56:908–943. Search in Google Scholar

6. National Cancer Institute. PDQ levels of evidence for adult and pediatric cancer treatment studies. National Cancer Institute. 2011. Search in Google Scholar

7. Taran Natalia DV-TT-S. Hepatocarcinomul celular: răspândire, factori de risc şi obţiuni de tratament. anat Publica, Econ Si Manag Med. 2014;138–42. Search in Google Scholar

8. Oprita Ruxandra. Controverse in diagnosticul si managementul hepatocarcinomului. Manag Clin Manag Sanat. 2014;XVIII(3):22–8. Search in Google Scholar

9. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86. Search in Google Scholar

10. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007 Jun;132(7):2557–76. Search in Google Scholar

11. Joseph FP, Armstrong GL, Farrington LA, Hutin YJF, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006;45(4):529-38. Search in Google Scholar

12. McPhee SJ, Papadakis MA, Rabow MW. Current Medical Diagnosis andTreatment. Fifty-Firs. New York; 2012. Search in Google Scholar

13. Llovet JM. Updated treatment approach to hepatocellular carcinoma. J Gastroenterol. 2005;40:225–235. Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo